Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation inhibition by mononuclear leukocytes

M A Schattner1, M R Finiasz, J A Notrica

  • 1Departamentos de Hemostasia y Trombosis e Inmunología Academia Nacional de Medicina, Buenos Aires, Argentina.

Thrombosis Research
|February 15, 1994
PubMed
Summary

Human mononuclear leukocytes (ML) inhibit platelet aggregation. This anti-aggregating effect is mediated by soluble factors, not surface molecules, and is potentiated by superoxide dismutase.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral blood monocyte and T cell subsets in children with specific polysaccharide antibody deficiency (SPAD).

Human immunology·2015
Same author

Immune response to Streptococcus pneumoniae in asthma patients: comparison between stable situation and exacerbation.

Clinical and experimental immunology·2013
Same author

Esophagojejunal reconstruction after total gastrectomy for gastric cancer using a transorally inserted anvil delivery system.

Annals of surgical oncology·2013
Same author

Clinical profile of the association of P.R1205h and P.R924q in a patient with von Willebrand's disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis.

Hematology (Amsterdam, Netherlands)·2012
Same author

C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significance.

Haemophilia : the official journal of the World Federation of Hemophilia·2011

Area of Science:

  • Immunology
  • Hematology
  • Cell Biology

Background:

  • Platelet aggregation is crucial for hemostasis and thrombosis.
  • Mononuclear leukocytes (ML) play roles in immune responses and may influence other cell types.
  • The interaction between leukocytes and platelets is complex and not fully understood.

Purpose of the Study:

  • To investigate the effect of human mononuclear leukocytes (ML) on platelet aggregation.
  • To elucidate the mechanisms underlying ML-mediated modulation of platelet function.
  • To identify soluble factors or cell surface molecules involved in this interaction.

Main Methods:

  • Coincubation of human platelets with nonstimulated mononuclear leukocytes (ML).
  • Induction of platelet aggregation using collagen or thrombin.

Related Experiment Videos

  • Analysis of platelet aggregation in response to ML, ML supernatants, and various modulators.
  • Assessment of soluble factors (e.g., 6-keto PGF1 alpha) and surface molecules (LFA-1 alpha, P-selectin) using specific antibodies.

    • Main Results:

    • Nonstimulated ML significantly decreased collagen- or thrombin-induced platelet aggregation in a concentration-dependent manner.
    • The inhibitory effect of ML on platelet aggregation increased with incubation time, plateauing at 5 minutes.
    • Supernatants from ML also inhibited platelet aggregation, suggesting the release of soluble factors.
    • Superoxide dismutase potentiated the anti-aggregating activity of ML, while other tested substances did not.
    • Monoclonal antibodies against LFA-1 alpha and P-selectin did not affect the inhibitory activity.

    Conclusions:

    • Human mononuclear leukocytes (ML) possess anti-aggregating activity against platelets.
    • This inhibition is mediated, at least partially, by soluble factors released by ML, distinct from prostacyclin or nitric oxide.
    • Cell surface adhesion molecules like LFA-1 alpha and P-selectin do not appear to be involved in the ML-mediated inhibition of platelet aggregation.